Constellation Brands Could Satisfy Your Thirst for a Trade From the Long Side

Aggressive traders could probe the long side of STZ at current levels and on a shallow dip.

Why Canada Rules as a Haven for Listing Cannabis Companies

The main reason most cannabis-related concerns head north to list their shares is banking.

How to Trade Cronos, the Cannabis Firm With Ties to Big Tobacco

What matters here is the ability to innovate, market, and sell.

Aphria's Hostile Takeover by Green Growth Doesn't Looks so Hostile

Both Aphria and Green Growth's stock prices have sold off since the announcement.

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Despite the current stock market, investors are still looking for ways to play the new legalization of hemp.

Who Hasn't Crashed the Cannabis Party Yet?

Establishing who the stragglers are and what impact they might have in the future is the key at this point.

Tilray Is Now a Top-Tier Cannabis Play

I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.

Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's

Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.

Chart of the Day, Part 1: Tilray, AB Deal Pales in Comparison to Cronos

The buy-in from other companies into the space has been far larger.

Can Tilray Launch a Rally for Itself and Other Cannabis Stocks? Let's See

Tilray's technical history is limited, but a bullish divergence in a key chart could be foreshadowing a rally ahead.